As of Jan 20
| -2.58 / -5.60%|
The 6 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 60.00, with a high estimate of 65.00 and a low estimate of 55.00. The median estimate represents a +37.93% increase from the last price of 43.50.
The current consensus among 7 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.